PXRB was joking about NVIV bid, evidently: https://finance.yahoo.com/news/pixarbio-corporation-terminates-invivo-therapeutics-110000863.html NVIV is +1%, which makes sense insofar as the threat of a takeunder has been lifted, LOL.